Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,937
datasets available to search
ShareScore release 0.9.0
Dataset results
2,937 results for “Multiple Myeloma”
Patients With Newly Diagnosed Multiple Myeloma Comparing KTd vs. KRd Induction Therapy and Investigating a K-mono Maintenance Strategy
ClinicalTrials.gov study NCT02891811. IPD Sharing: NO. Countries: 2. Publications: 0.
Combined Bone Marrow Transplantation (BMT) and Renal Transplant for Multiple Myeloma (MM) With End Stage Renal Disease (ESRD)
ClinicalTrials.gov study NCT00854139. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chemotherapy With or Without Wobe-Mugos E in Treating Patients With Stage II or Stage III Multiple Myeloma
ClinicalTrials.gov study NCT00014339. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase III, Open-label, Randomised, Multicentre Study to Evaluate AZD0120 in Participants With Relapsed Refractory Multiple Myeloma.
ClinicalTrials.gov study NCT07391657. IPD Sharing: YES. Countries: 13. Publications: 0.
Iberdomide, Daratumumab, Carfilzomib, and Dexamethasone (Iber-KDd) in Patients With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT05896228. IPD Sharing: NO. Countries: 1. Publications: 0.
Quantitative and Qualitative Monocytes Analysis and Their Impact on CART Cells Reponse in Multiple Myeloma
ClinicalTrials.gov study NCT07180992. IPD Sharing: NO. Countries: 1. Publications: 0.
CKD-581 + Lenalidomide + Dexamethasone in Patients With Previously Treated Multiple Myeloma
ClinicalTrials.gov study NCT03150316. IPD Sharing: NO. Countries: 1. Publications: 0.
A Nationwide Phase 2 Trial of Patients With Smoldering and Active Multiple Myeloma (MM)
ClinicalTrials.gov study NCT03815279. IPD Sharing: NO. Countries: 1. Publications: 0.
Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell Disorders
ClinicalTrials.gov study NCT00258258. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Safety and Efficacy of Pomalidomide in Combination With Cyclophosphamide and Dexamethasone (PCD) in the Transplant-ineligible Patients With Relapsed and/or Refractory Multiple Myeloma (MM)
ClinicalTrials.gov study NCT03242460. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00003195. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I/II Study of BI-505 in Conjunction With Autologous Stem Cell Transplant in Multiple Myeloma
ClinicalTrials.gov study NCT02756728. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase I Study to Assess the Tolerability of 225Ac-DOTATATE in Patients With Refractory and Relapsing Multiple Myeloma Expressing Somatostatin Receptors
ClinicalTrials.gov study NCT06411301. IPD Sharing: NO. Countries: 1. Publications: 0.
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
ClinicalTrials.gov study NCT04566328. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Study of ABBV-383 Assessing Adverse Events and Clinical Activity With Subcutaneous (SC) Injection in Adult Participants With Relapsed or Refractory Multiple Myeloma
ClinicalTrials.gov study NCT06223516. IPD Sharing: NO. Countries: 4. Publications: 0.
ASCT Combined With BCMA CAR-T and GPRC5D/CD3 BiTEs Maintenance for Transplant-Eligible Ultra-High-Risk Multiple Myeloma
ClinicalTrials.gov study NCT07106710. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy Study of ZD6474 to Treat Multiple Myeloma Cancer
ClinicalTrials.gov study NCT00047788. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Combination Chemotherapy With or Without High Dose Cyclophosphamide and Recombinant Interferon Alfa-2b in Treating Patients With Previously Untreated Stage I-III Multiple Myeloma
ClinicalTrials.gov study NCT00002556. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Risk Factors and Genetic Association With Bortezomib-induced Peripheral Neuropathy in Multiple Myeloma
ClinicalTrials.gov study NCT03210753. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Assessment of Early Detection and Prognosis Based on cfDNA Methylation in Multiple Myeloma
ClinicalTrials.gov study NCT05693012. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.